Publications by authors named "Charlene Flournoy"
Article Synopsis
- The study assessed eligibility rates for participation in Alzheimer's disease (AD) clinical trials among different racial and ethnic groups across the U.S.
- Out of 10,804 screened participants, there was a significant underrepresentation of Hispanic and Black participants, with higher chances of ineligibility based on amyloid biomarker criteria compared to their non-Hispanic White counterparts.
- The findings suggest that varying eligibility criteria may contribute to the underrepresentation of certain minored groups in early AD trials, which could impact treatment outcomes and research efficacy.
